Fig. 1From: Individualisation of radiation protection recommendations for patients treated with [177Lu]Lu-DOTA-TATECurves of the remaining whole-body activity as a function of time for the first and the fourth cycle corresponding to the 16 patients for whom those data were available, including an uncertainty in the remaining whole-body activity of 20%Back to article page